GAITHERSBURG, MD, United States of America

Ryan Gilbreth

This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryan Gilbreth. Retrieved from https://idiyas.com/inventor/ryan-gilbreth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryan Gilbreth: Innovator in Cancer Treatment

Introduction

Ryan Gilbreth is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of advanced therapeutic methods.

Latest Patents

Ryan holds 1 patent for his work titled "Compositions and methods of treating cancer with chimeric antigen receptors." This patent focuses on the use of armored chimeric antigen receptor cells to treat cancer, showcasing his commitment to improving patient outcomes through innovative medical solutions.

Career Highlights

Throughout his career, Ryan has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and MedImmune Limited. His experience in these organizations has allowed him to develop and refine his expertise in cancer therapies.

Collaborations

Ryan has collaborated with several professionals in his field, including Michael Glen Overstreet and Gordon Moody. These partnerships have contributed to his success and the advancement of his research.

Conclusion

Ryan Gilbreth's work in cancer treatment exemplifies the impact of innovation in medicine. His dedication to developing effective therapies continues to inspire advancements in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…